H35.3123 Nonexudative age-related macular degeneration, left eye, advanced atrophic without subfoveal involvement

Name of the Condition

• Nonexudative Age-Related Macular Degeneration, Left Eye, Advanced Atrophic Without Subfoveal Involvement

Summary

Nonexudative age-related macular degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp, detailed vision. This advanced atrophic form, also called "dry" AMD, involves significant macular thinning and atrophy without fluid leakage or bleeding. Vision loss is typically progressive and may impact central vision in the left eye, though subfoveal involvement is absent.

Causes

The exact cause of nonexudative AMD is not fully understood, but it involves the natural aging process of retinal cells. Key factors include the buildup of drusen (yellowish deposits) under the retina, oxidative stress, and chronic inflammation, which can damage retinal tissues over time. Advanced atrophy occurs as the macula thins and loses function.

Risk Factors

• Increasing age, particularly over 50.
• Family history of macular degeneration.
• Smoking and tobacco exposure.
• Obesity and high cholesterol.
• Poor diet lacking antioxidants and zinc.
• Cardiovascular disease and hypertension.

Symptoms

• Blurred or reduced central vision in the left eye.
• Difficulty reading or recognizing faces.
• Need for brighter lighting when performing tasks.
• Distorted or wavy vision (less common in advanced stages).

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilation to inspect the retina. Optical coherence tomography (OCT) provides detailed retinal layer imaging to confirm atrophy. Fluorescein angiography may be used to rule out subfoveal involvement or other complications. Patient history and visual acuity tests are also assessed.

Treatment Options

• Antioxidant and zinc supplements (AREDS formula) to slow progression.
• Lifestyle modifications such as smoking cessation and diet improvement.
• Regular monitoring with OCT to track atrophy changes.
• Low-vision aids for managing vision loss.

Prognosis and Follow-Up

Prognosis depends on the rate of atrophy progression. Vision loss is typically gradual but may stabilize with proper management. Regular follow-up with an eye care professional is essential to monitor for complications or subfoveal involvement. Early detection of changes can help adjust treatment plans.

Complications

• Progressive central vision loss.
• Difficulty with daily tasks requiring detailed vision.
• Increased risk of developing exudative (wet) AMD in the same or fellow eye.

Lifestyle & Prevention

• Maintain a diet rich in leafy greens, fish, and antioxidants.
• Avoid smoking and limit alcohol consumption.
• Protect eyes from UV light with sunglasses.
• Manage cardiovascular health through exercise and blood pressure control.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, such as blurriness, distortion, or dark spots, as these may indicate subfoveal involvement or progression to exudative AMD.

Tips for Medical Coders

Document the advanced atrophic stage and absence of subfoveal involvement clearly in the medical record. Ensure the left eye specification and nonexudative nature are accurately reflected. Use supporting clinical notes to confirm the diagnosis and stage for coding accuracy.